Brainstorm Cell Therapeutics Inc Share Price

NASDAQ: BCLI

$0.71

-0.46

(-39.64%)

as on September 16, 2025 at 1:25 am IST

$₹

The stock has been delisted from the stock exchange on 17 Jul 2025

Brainstorm Cell Therapeutics Inc Stock Performance

as on September 16, 2025 at 1:25 am IST

Day's Low
Day's High
$0.58
Day's Price Range
$0.58
$0.71
18.31%
Downside
-18.31%
Upside
52 Week's Low
52 Week's High
$0.72
52-Week Price Range
$4.55
$0.71
-1.87%
Downside
540.14%
Upside

Brainstorm Cell Therapeutics Inc share price movements today

Previous Close: $1.17
Open: $0.58
Volume: 1.0K
Day's Low - High: $0.58 - $0.58
52 Week Low - High: $0.72 - $4.55

Brainstorm Cell Therapeutics Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Brainstorm Cell Therapeutics Inc Stock Fundamentals & Key Indicators

Check Brainstorm Cell Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

0.00%

Brainstorm Cell Therapeutics Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Brainstorm Cell Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Brainstorm Cell Therapeutics Inc	SELL	$-	NA	NA	0.00%

Analyst Recommendation on Brainstorm Cell Therapeutics Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Brainstorm Cell Therapeutics Inc. Average target price of $13.12

Brainstorm Cell Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Brainstorm Cell Therapeutics Inc.

What analysts predicted

94.59%UPSIDE

Target Price

$13.12

Current Price

$0.71

Analyzed by

6 Analysts

Target

$13.12

Brainstorm Cell Therapeutics Inc target price $13.12, a slight upside of 94.59% compared to current price of $0.71. According to 6 analysts rating.

Brainstorm Cell Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	0	-	0	0	-	0	0	-	-	-
Gross Profit	0	0	0	0	0	0	0	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-6	-5	-5	-5	-1	-3	-2	-2	-2	-2
Net Profit Margin	-1446.84%	0.00%	1017.91%	-3460.39%	0.00%	-991.55%	-696.16%	0.00%	0.00%	0.00%

Brainstorm Cell Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	0	-	-	-	-	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-8	-4	-4	-13	-23	-31	-24	-23	-17	11
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	6353.28%	0.00%	0.00%	0.00%	0.00%	1369.02%

Global Institutional Holdings in Brainstorm Cell Therapeutics Inc

Funds	Holdings
Armistice Capital, LLC	7.02%
CALDWELL SUTTER CAPITAL INC	1.6%
Geode Capital Management, LLC	0.59%
Vanguard Group Inc	0.28%
BlackRock Inc	0.26%

See all

About Brainstorm Cell Therapeutics Inc

Brainstorm Cell Therapeutics Inc. is a biotechnology company. The Company is in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease; progressive multiple sclerosis (PMS); Alzheimer’s disease (AD); and other neurodegenerative diseases. Its NurOwn, a cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived MSCs to secrete high levels of neurotrophic factors (NTFs), modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function. It has completed a Phase III pivotal trial in ALS (NCT03280056); this trial investigated the safety and efficacy of repeat-administration of autologous MSC-NTF cells. The Company's wholly owned subsidiary, Brainstorm Cell Therapeutics Ltd. holds exclusive rights to commercialize NurOwn technology.

Organisation	Brainstorm Cell Therapeutics Inc
E-voting on shares	Click here to vote

FAQs

What is Brainstorm Cell Therapeutics Inc share price today?

Brainstorm Cell Therapeutics Inc share price today is $0.71 as on September 16, 2025 at 1:25 am IST at the close of the market. Brainstorm Cell Therapeutics Inc share today touched a day high of $0.58 and a low of $0.58.

What is the 52 week high and 52 week low for Brainstorm Cell Therapeutics Inc share?

Brainstorm Cell Therapeutics Inc share touched a 52 week high of $4.55 on September 16, 2024 and a 52 week low of $0.72 on April 16, 2025. Brainstorm Cell Therapeutics Inc stock price today i.e. September 16, 2025 at 1:25 am IST is closed at $0.71,which is 84.38% down from its 52 week high and -1.84% up from its 52 week low.

How to invest in Brainstorm Cell Therapeutics Inc Stock (BCLI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Brainstorm Cell Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Brainstorm Cell Therapeutics Inc Shares that will get you 2.1127 shares as per Brainstorm Cell Therapeutics Inc share price of $0.71 per share as on September 16, 2025 at 1:25 am IST.

What is the minimum amount required to buy Brainstorm Cell Therapeutics Inc Stock (BCLI) from India?

Indian investors can start investing in Brainstorm Cell Therapeutics Inc (BCLI) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 3:23 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Brainstorm Cell Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 3:23 am IST). Based on Brainstorm Cell Therapeutics Inc share’s latest price of $0.71 as on September 16, 2025 at 1:25 am IST, you will get 14.0845 shares of Brainstorm Cell Therapeutics Inc. Learn more about fractional shares .